The Institute for Protein Design is an innovation factory. Since launching a decade ago, the University of Washington institution has grown to about 200 researchers and spun out eight startups… Read More
Seattle-based vaccine company Icosavax posted disappointing clinical data today for its experimental COVID-19 vaccine, sending its stock into a dive. Icosavax went public last June in an IPO that raised… Read More
Seattle-based Icosavax has filed to go public via an IPO, just four years after it launched out of the University of Washington. The company, a spin-out from the UW’s Institute… Read More
Seattle-based biotech startup Icosavax today scored $51 million in funding to create vaccines from artificial viruses. The Series A financing was led by Qiming Venture Partners USA along with Adams… Read More